VY
Vynleads, Inc.
VYND · OTC
$0.41 +0.00% (+$0.00)
Market Cap $7.51M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.26
36.6% downside
Current Price
$0.41
Undervalued Fair Value Overvalued
According to Bulios Fair Price, VYND is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 124.00%
ROA 1,018.92%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.06x
Int. coverage -74.52x
Debt/Equity N/A
Stability
44 /100
Moderate Beta 5.05x
EPS volatility 14.71%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VYND
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Alex J. Mannine
Employees
1
Headquarters
Rock Hill